Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 5
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2213MYCProteinHumanDownregulated in HCC DiagnosticHBV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2218MYCProteinHumanDownregulated in HCC DiagnosticHCV-associated HCC v/s healthy/non-tumor/cirrhosis p < 0.0001Tissue28947976
2322MycRNAsHumanUpegulated in HCC than non-tumor Prognosticearly occurrence v/s late recurrence NATissue20380719
2506Zinc finger protein, integrin alpha 6, hepatoma derived growth factor, TGF beta induced, Macrophage inhibitory cytokine 1, lymphocyte antigen, aldehyde oxidase, c-myc purine binding transcription factor puf, plasminogen, vitronectin, hemoglobin alpha subunit, cytosolic superoxide dismutase, methylenRNAsHumanDiffrenetially expressed in moderately differentiated HCC v/s poorly differentiated HCC Diagnosticmoderately differentiated HCC v/s poorly differentiated HCC p < 0.01Tissue11973655
2525Cytoplasmic dynein light chain, Hepatoma-derived growth factor, Ribosomal protein L6, glutathioneS-transferase, Fibronectin, Ras homolog gene family member B, TR3 orphan receptor, c-myc transcription factor (puf), MHC-class ICRNAsHumanUpregulated in HCC than non-tumorous tissue ( with average ratio more than 2) DiagnosticHCC v/s non-tumor NATissue11283847

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top